Search

everythinglearnresearchcommunity

for

Search:↓

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Suppressing certain hormones might help prevent prostate cancer.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Early balding at 40 increases prostate cancer risk.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

A new compound was effective for imaging prostate cancer in rats.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Finasteride treats hair loss but may affect prostate cancer detection.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Targeting colon cancer stem cells might lead to better treatment results.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.